Section g3 and h4: correction.Manufacturer's investigation conclusion: a specific cause for the reported cardiac arrhythmia and frequent pi events, as well as a direct correlation to heartmate 3 lvas, serial number (b)(6), and to each other, could not conclusively be determined through this evaluation.The reported frequent pi events could not be confirmed as no log files were submitted for review.The account communicated that the patient had ventricular tachycardia with a heartrate of 200 bpm on (b)(6) 2019.Log file analysis reportedly showed multiple pi events but device interrogation showed normal lvad function and parameters appeared appropriate.There were no alarms associated with this event.Additional information was requested, but not provided.The patient remains ongoing on heartmate 3 lvas, serial number (b)(6).No product is available for investigation.It was noted that the patient continued to have issues with cardiac arrhythmia and frequent pi events on (b)(6) 2020 (referenced in manufacturer report number #2916596-2020-04419).The heartmate 3 lvas ifu lists cardiac arrhythmia as an adverse event that may be associated with the use of the heartmate 3 left ventricular assist system.The heartmate 3 lvas ifu also provides an explanation of each of the pump parameters (including pulsatility index), addresses pi events as well as potential causes, and explains how to determine the optimal fixed speed and low speed limit for the patient.This document additionally states that there are no audible alarms with a pi event.The relevant sections of the device history records for (b)(6) and the percutaneous lead were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on (b)(6) 2017.No further information was provided.The manufacturer is closing the file on this event.
|